Literature DB >> 22333911

Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndrome.

E Radulescu1, B Ganeshan, L Minati, F D C C Beacher, M A Gray, C Chatwin, R C D Young, N A Harrison, H D Critchley.   

Abstract

Brain imaging studies contribute to the neurobiological understanding of Autism Spectrum Conditions (ASC). Herein, we tested the prediction that distributed neurodevelopmental abnormalities in brain development impact on the homogeneity of brain tissue measured using texture analysis (TA; a morphological method for surface pattern characterization). TA was applied to structural magnetic resonance brain scans of 54 adult participants (24 with Asperger syndrome (AS) and 30 controls). Measures of mean gray-level intensity, entropy and uniformity were extracted from gray matter images at fine, medium and coarse textures. Comparisons between AS and controls identified higher entropy and lower uniformity across textures in the AS group. Data reduction of texture parameters revealed three orthogonal principal components. These were used as regressors-of-interest in a voxel-based morphometry analysis that explored the relationship between surface texture variations and regional gray matter volume. Across the AS but not control group, measures of entropy and uniformity were related to the volume of the caudate nuclei, whereas mean gray-level was related to the size of the cerebellar vermis. Similar to neuropathological studies, our study provides evidence for distributed abnormalities in the structural integrity of gray matter in adults with ASC, in particular within corticostriatal and corticocerebellar networks. Additionally, this in-vivo technique may be more sensitive to fine microstructural organization than other more traditional magnetic resonance approaches and serves as a future testable biomarker in AS and other neurodevelopmental disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22333911     DOI: 10.1038/tpj.2012.3

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  6 in total

1.  CT texture analysis of renal masses: pilot study using random forest classification for prediction of pathology.

Authors:  Siva P Raman; Yifei Chen; James L Schroeder; Peng Huang; Elliot K Fishman
Journal:  Acad Radiol       Date:  2014-09-16       Impact factor: 3.173

2.  Sex differences and autism: brain function during verbal fluency and mental rotation.

Authors:  Felix D C C Beacher; Eugenia Radulescu; Ludovico Minati; Simon Baron-Cohen; Michael V Lombardo; Meng-Chuan Lai; Anne Walker; Dawn Howard; Marcus A Gray; Neil A Harrison; Hugo D Critchley
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

3.  Identification of voxel-based texture abnormalities as new biomarkers for schizophrenia and major depressive patients using layer-wise relevance propagation on deep learning decisions.

Authors:  A I Korda; A Ruef; S Neufang; C Davatzikos; S Borgwardt; E M Meisenzahl; N Koutsouleris
Journal:  Psychiatry Res Neuroimaging       Date:  2021-05-16       Impact factor: 2.493

4.  Abnormalities in fronto-striatal connectivity within language networks relate to differences in grey-matter heterogeneity in Asperger syndrome.

Authors:  Eugenia Radulescu; Ludovico Minati; Balaji Ganeshan; Neil A Harrison; Marcus A Gray; Felix D C C Beacher; Chris Chatwin; Rupert C D Young; Hugo D Critchley
Journal:  Neuroimage Clin       Date:  2013-05-27       Impact factor: 4.881

5.  In Vivo Imaging of Tau Pathology Using Magnetic Resonance Imaging Textural Analysis.

Authors:  Niall Colgan; Balaji Ganeshan; Ian F Harrison; Ozama Ismail; Holly E Holmes; Jack A Wells; Nick M Powell; James M O'Callaghan; Michael J O'Neill; Tracey K Murray; Zeshan Ahmed; Emily C Collins; Ross A Johnson; Ashley Groves; Mark F Lythgoe
Journal:  Front Neurosci       Date:  2017-11-06       Impact factor: 4.677

Review 6.  Behavioral, Cognitive and Neural Markers of Asperger Syndrome.

Authors:  Farnaz Faridi; Reza Khosrowabadi
Journal:  Basic Clin Neurosci       Date:  2017 Sep-Oct
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.